A novel hypothesis of atherosclerosis: EPCs-mediated repair-to-injury
- PMID: 17920780
- DOI: 10.1016/j.mehy.2007.06.041
A novel hypothesis of atherosclerosis: EPCs-mediated repair-to-injury
Abstract
Recent findings demonstrate the vital role of endothelial progenitor cells in the homeostasis of the vessel wall and the development of atherosclerosis. Endothelial progenitor cells (EPCs) play important roles in repair-to-injury of arteries. Many evidences have shown Cardiovascular risk factors closely correlated with EPCs numbers and function. Levels of circulating EPCs represented a better predictor of endothelial function than conventional risk factors. Depletion of bone marrow and Cardiovascular risk factors are the two prerequisits of atherosclerosis. All conditions of manifest atherosclerotic disease are accompanied by reduced EPC numbers and migratory capacity. Therefore, based on response-to-injury hypothesis and these findings, we build up EPCs-mediated repair-to-injury hypothesis, which may have important therapeutic implications in the prevention and therapy of atherosclerosis. The use of EPCs for vascular repair may be important therapy strategies with a maximized benefit for the patient in the future.
Similar articles
-
[Endothelial progenitor cells and atherosclerosis].Harefuah. 2006 May;145(5):358-61, 397. Harefuah. 2006. PMID: 16805218 Review. Hebrew.
-
Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):257-66. doi: 10.1161/01.ATV.0000198239.41189.5d. Epub 2005 Dec 1. Arterioscler Thromb Vasc Biol. 2006. PMID: 16322535 Review.
-
Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair.Circulation. 2005 Jun 7;111(22):2981-7. doi: 10.1161/CIRCULATIONAHA.104.504340. Epub 2005 May 31. Circulation. 2005. PMID: 15927972
-
Endothelial progenitor cells are reduced in refractory hypertension.J Hum Hypertens. 2008 Mar;22(3):183-90. doi: 10.1038/sj.jhh.1002304. Epub 2007 Nov 8. J Hum Hypertens. 2008. PMID: 17992252
-
Endothelial progenitor cells: a promising therapeutic alternative for cardiovascular disease.J Interv Cardiol. 2007 Apr;20(2):93-9. doi: 10.1111/j.1540-8183.2007.00251.x. J Interv Cardiol. 2007. PMID: 17391216 Review.
Cited by
-
Endothelial Progenitor Cell Levels and Extent of Post-prandial Lipemic Response.Front Nutr. 2022 Feb 14;9:822131. doi: 10.3389/fnut.2022.822131. eCollection 2022. Front Nutr. 2022. PMID: 35237643 Free PMC article.
-
Functional Impairment of Endothelial Colony Forming Cells (ECFC) in Patients with Severe Atherosclerotic Cardiovascular Disease (ASCVD).Int J Mol Sci. 2022 Aug 11;23(16):8969. doi: 10.3390/ijms23168969. Int J Mol Sci. 2022. PMID: 36012229 Free PMC article.
-
Carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein phosphorylation: evidence for blunted responsiveness in diabetes.Diabetes. 2008 Sep;57(9):2488-94. doi: 10.2337/db08-0381. Epub 2008 Jun 16. Diabetes. 2008. PMID: 18559661 Free PMC article.
-
The effect of Xuefu Zhuyu Decoction on in vitro endothelial progenitor cell tube formation.Chin J Integr Med. 2010 Feb;16(1):50-3. doi: 10.1007/s11655-010-0050-y. Epub 2010 Feb 4. Chin J Integr Med. 2010. PMID: 20131036 Free PMC article.
-
Effects of dulaglutide on endothelial progenitor cells and arterial elasticity in patients with type 2 diabetes mellitus.Cardiovasc Diabetol. 2022 Oct 3;21(1):200. doi: 10.1186/s12933-022-01634-1. Cardiovasc Diabetol. 2022. PMID: 36199064 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical